PH15198A - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number: PH15198A
Authority: PH; Philippines
Prior art keywords: therapeutic agents; therapeutic; agents
Prior art date: 1979-03-07

Application number

PH23726A

Other languages

English (en)

Inventor

Peter Edward Cross

Roger Peter Dickinson

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-03-07

Filing date

1980-03-05

Publication date

1982-09-17

1980-03-05 Application filed by Pfizer filed Critical Pfizer

1982-09-17 Publication of PH15198A publication Critical patent/PH15198A/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

PH23726A 1979-03-07 1980-03-05 Therapeutic agents PH15198A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB7908123		1979-03-07

Publications (1)

Publication Number	Publication Date
PH15198A true PH15198A (en)	1982-09-17

Family

ID=10503707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH23726A PH15198A (en)	1979-03-07	1980-03-05	Therapeutic agents

Country Status (36)

Country	Link
US (1)	US4273782A (nl)
JP (1)	JPS55133380A (nl)
KR (1)	KR850000760B1 (nl)
AR (1)	AR227015A1 (nl)
AT (1)	AT375366B (nl)
AU (1)	AU516957B2 (nl)
BE (1)	BE882113A (nl)
CA (1)	CA1120479A (nl)
CH (1)	CH649546A5 (nl)
CS (1)	CS253702B2 (nl)
DD (1)	DD149525A5 (nl)
DE (1)	DE3008632A1 (nl)
DK (1)	DK151884C (nl)
ES (2)	ES8104278A1 (nl)
FI (1)	FI66860C (nl)
FR (1)	FR2450832A1 (nl)
GR (1)	GR67237B (nl)
HK (1)	HK89884A (nl)
HU (1)	HU184727B (nl)
IE (1)	IE49542B1 (nl)
IL (1)	IL59524A (nl)
IT (1)	IT1218420B (nl)
KE (1)	KE3467A (nl)
LU (1)	LU82224A1 (nl)
MY (1)	MY8500285A (nl)
NL (1)	NL182959C (nl)
NO (1)	NO152217C (nl)
NZ (1)	NZ193052A (nl)
PH (1)	PH15198A (nl)
PL (1)	PL128296B1 (nl)
PT (1)	PT70914A (nl)
SE (1)	SE440778B (nl)
SG (1)	SG67284G (nl)
SU (1)	SU1277894A3 (nl)
YU (1)	YU41911B (nl)
ZA (1)	ZA801328B (nl)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4414159A (en) *	1980-09-26	1983-11-08	E. I. Du Pont De Nemours & Co.	Vinyl ether monomers and polymers therefrom
US4444775A (en) *	1981-06-22	1984-04-24	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridines
KR840000529A (ko) *	1981-07-07	1984-02-25	콘스탄틴 루이스 클레멘트	인돌 유도체의 제조방법
ZA825413B (en) *	1981-08-26	1983-06-29	Pfizer	Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4460777A (en) *	1981-11-19	1984-07-17	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4478842A (en) *	1981-11-19	1984-10-23	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4539410A (en) *	1982-09-30	1985-09-03	Ciba-Geigy Corporation	N-Substituted-2-(1-imidazolyl)indoles
US4436746A (en)	1982-09-30	1984-03-13	Ciba-Geigy Corporation	Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
AT376436B (de) *	1982-11-05	1984-11-26	Laevosan Gmbh & Co Kg	Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon
US4511573A (en) *	1983-05-17	1985-04-16	Ciba-Geigy Corporation	3-Substituted-2-(heteroaryl) indoles
DE3786030T2 (de)	1986-03-27	1993-12-02	Merck Frosst Canada Inc	Tetrahydrocarbazole Ester.
JPH0832679B2 (ja) *	1986-09-05	1996-03-29	理化学研究所	Ｎ―フタルイシド誘導体及びその製造法
GR871809B (en) *	1986-11-28	1988-03-07	Glaxo Group Ltd	Process for the preparation of tricyclic ketones
EP0427860A1 (en) *	1989-03-31	1991-05-22	Kyoto Pharmaceutical Industries, Ltd.	New imidazole derivatives, production thereof, and uses thereof as medicines
DE4023215A1 (de) *	1990-07-21	1992-01-23	Hoechst Ag	Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
PT98927A (pt) *	1990-09-13	1992-07-31	Beecham Group Plc	Processo para a preparacao de piridil-indolil-ureias
US5162337A (en) *	1990-10-05	1992-11-10	Merck & Co., Inc.	Animal growth promotion
US5120749A (en) *	1991-02-20	1992-06-09	Abbott Laboratories	Platelet activating antagonists
NZ246441A (en) *	1991-12-18	1996-02-27	Schering Corp	Imidazol or imidazolalkyl substituted with a 4 or 5 membered nitrogen containing heterocycle, preparation and pharmaceutical compositions thereof
US5538973A (en) *	1992-03-27	1996-07-23	Kyoto Pharmaceutical Industries, Ltd.	Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
CA2109931A1 (en) *	1992-03-27	1993-10-14	Hiroshi Matsui	Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor
JPH0632913U (ja) *	1992-09-18	1994-04-28	三洋電機株式会社	床暖房用パネル
WO1999050268A2 (en) *	1998-03-31	1999-10-07	The Institutes For Pharmaceutical Discovery, Inc.	Substituted indolealkanoic acids
MXPA05006282A (es) *	2002-12-10	2005-08-19	Wyeth Corp	Derivados del acido 1h-indol-1-il acetico de 3-alquilo y 3-arilalquilo sustituido como inhibidores del inhibidor-1 de activador de plasminogeno (pai-1).
GB0324763D0 (en)	2003-10-23	2003-11-26	Oxagen Ltd	Use of compounds in therapy
KR20070091607A (ko) *	2004-10-12	2007-09-11	디코드 제네틱스, 아이엔씨.	폐쇄성 동맥 질환용의 설폰아미드 주변 치환된바이사이클릭 화합물
SG165314A1 (en) *	2005-08-25	2010-10-28	Schering Corp	Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists
US8399666B2 (en) *	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en)	2005-11-04	2011-07-12	Amira Pharmaceuticals, Inc.	5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) *	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
US7579483B2 (en) *	2006-05-16	2009-08-25	Decode Genetics, Ehf.	Process for preparing 7-(acryloyl)indoles
US7999119B2 (en)	2006-07-22	2011-08-16	Oxagen Limited	Compounds having CRTH2 antagonist activity
TW200920369A (en) *	2007-10-26	2009-05-16	Amira Pharmaceuticals Inc	5-lipoxygenase activating protein (flap) inhibitor
EP2234608A2 (en)	2007-12-11	2010-10-06	Viamet Pharmaceuticals, Inc.	Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
US7750027B2 (en) *	2008-01-18	2010-07-06	Oxagen Limited	Compounds having CRTH2 antagonist activity
MX2010007833A (es)	2008-01-18	2010-08-11	Oxagen Ltd	Compuestos que tienen actividad antagonista de crth2.
JP2011509990A (ja) *	2008-01-22	2011-03-31	オキサジェンリミテッド	Ｃｒｔｈ２アンタゴニスト活性を有する化合物
US8168673B2 (en) *	2008-01-22	2012-05-01	Oxagen Limited	Compounds having CRTH2 antagonist activity
CA2724726C (en) *	2008-05-23	2018-02-27	Amira Pharmaceuticals, Inc.	5-lipoxygenase-activating protein inhibitor
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
CN103929961A (zh) *	2011-06-20	2014-07-16	美国阿尔茨海默病研究所公司	化合物及其治疗应用
GB201322273D0 (en)	2013-12-17	2014-01-29	Atopix Therapeutics Ltd	Process
GB201407807D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
GB201407820D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
WO2019191410A1 (en) *	2018-03-29	2019-10-03	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Inhibitors for the β-catenin / t-cell factor protein–protein interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL125443C (nl) *	1963-06-06
US3370063A (en) *	1964-10-05	1968-02-20	Mcneilab Inc	Substituted dimethoxy indoles and method of making the same
US3621027A (en) *	1968-03-18	1971-11-16	Endo Lab	1-aminoalkyl-2,6-diaryl 4,5,6,7 tetrahydro-4-oxindales
US3931229A (en) *	1973-08-23	1976-01-06	Warner-Lambert Company	3-Thiomethyl-2[2-(dialkylamino)ethyl]indoles
US4059583A (en) *	1975-11-13	1977-11-22	Mcneil Laboratories, Incorporated	Substituted indoles
AU523536B2 (en) *	1977-08-26	1982-08-05	Wellcome Foundation Limited, The	Imidazoles and methods of preparing them
US4140858A (en) *	1977-12-19	1979-02-20	Warner-Lambert Company	3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a method for their production
EP0003901B1 (en) *	1978-02-24	1981-08-05	Pfizer Limited	3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them

1980
- 1980-01-31 DK DK042580A patent/DK151884C/da active
- 1980-03-04 HU HU80498A patent/HU184727B/hu not_active IP Right Cessation
- 1980-03-04 CS CS801492A patent/CS253702B2/cs unknown
- 1980-03-05 SE SE8001736A patent/SE440778B/sv not_active IP Right Cessation
- 1980-03-05 LU LU82224A patent/LU82224A1/fr unknown
- 1980-03-05 ES ES489220A patent/ES8104278A1/es not_active Expired
- 1980-03-05 PH PH23726A patent/PH15198A/en unknown
- 1980-03-05 YU YU614/80A patent/YU41911B/xx unknown
- 1980-03-05 SU SU802891745A patent/SU1277894A3/ru active
- 1980-03-05 GR GR61368A patent/GR67237B/el unknown
- 1980-03-05 US US06/127,298 patent/US4273782A/en not_active Expired - Lifetime
- 1980-03-05 PL PL1980222470A patent/PL128296B1/pl unknown
- 1980-03-05 IL IL59524A patent/IL59524A/xx unknown
- 1980-03-05 NZ NZ193052A patent/NZ193052A/en unknown
- 1980-03-05 FI FI800672A patent/FI66860C/fi not_active IP Right Cessation
- 1980-03-06 NO NO800650A patent/NO152217C/no unknown
- 1980-03-06 JP JP2856380A patent/JPS55133380A/ja active Granted
- 1980-03-06 IE IE453/80A patent/IE49542B1/en not_active IP Right Cessation
- 1980-03-06 ZA ZA00801328A patent/ZA801328B/xx unknown
- 1980-03-06 AR AR280198A patent/AR227015A1/es active
- 1980-03-06 DD DD80219495A patent/DD149525A5/de not_active IP Right Cessation
- 1980-03-06 IT IT20399/80A patent/IT1218420B/it active
- 1980-03-06 NL NLAANVRAGE8001351,A patent/NL182959C/nl not_active IP Right Cessation
- 1980-03-06 CA CA000347143A patent/CA1120479A/en not_active Expired
- 1980-03-06 AT AT0125780A patent/AT375366B/de not_active IP Right Cessation
- 1980-03-06 AU AU56231/80A patent/AU516957B2/en not_active Ceased
- 1980-03-06 CH CH1781/80A patent/CH649546A5/de not_active IP Right Cessation
- 1980-03-06 FR FR8005054A patent/FR2450832A1/fr active Granted
- 1980-03-06 BE BE0/199699A patent/BE882113A/fr not_active IP Right Cessation
- 1980-03-06 DE DE19803008632 patent/DE3008632A1/de active Granted
- 1980-03-06 KR KR1019800000931A patent/KR850000760B1/ko active
- 1980-03-06 PT PT70914A patent/PT70914A/pt not_active IP Right Cessation
- 1980-11-14 ES ES496889A patent/ES8205789A1/es not_active Expired
1984
- 1984-09-21 SG SG67284A patent/SG67284G/en unknown
- 1984-10-05 KE KE3467A patent/KE3467A/xx unknown
- 1984-11-15 HK HK898/84A patent/HK89884A/xx unknown
1985
- 1985-12-30 MY MY285/85A patent/MY8500285A/xx unknown

Also Published As

Publication number	Publication date
FR2450832A1 (fr)	1980-10-03
HK89884A (en)	1984-11-23
DE3008632A1 (de)	1980-10-16
NO800650L (no)	1980-09-08
ES489220A0 (es)	1981-04-01
CA1120479A (en)	1982-03-23
FI66860B (fi)	1984-08-31
CH649546A5 (de)	1985-05-31
JPS55133380A (en)	1980-10-17
KR830001928A (ko)	1983-05-19
SE8001736L (sv)	1980-09-08
FR2450832B1 (nl)	1983-04-22
HU184727B (en)	1984-10-29
IE800453L (en)	1980-09-07
FI66860C (fi)	1984-12-10
NL8001351A (nl)	1980-09-09
GR67237B (nl)	1981-06-25
IT8020399A0 (it)	1980-03-06
DK151884B (da)	1988-01-11
ATA125780A (de)	1983-12-15
US4273782A (en)	1981-06-16
ES8104278A1 (es)	1981-04-01
IE49542B1 (en)	1985-10-30
IL59524A (en)	1982-11-30
PT70914A (en)	1980-04-01
DD149525A5 (de)	1981-07-15
MY8500285A (en)	1985-12-31
PL128296B1 (en)	1984-01-31
YU61480A (en)	1983-12-31
ZA801328B (en)	1981-03-25
LU82224A1 (fr)	1980-06-06
BE882113A (fr)	1980-09-08
AU516957B2 (en)	1981-07-02
KR850000760B1 (ko)	1985-05-25
SG67284G (en)	1985-03-15
KE3467A (en)	1984-11-09
NO152217C (no)	1985-08-21
DE3008632C2 (nl)	1988-02-25
DK42580A (da)	1980-09-08
NO152217B (no)	1985-05-13
YU41911B (en)	1988-02-29
FI800672A (fi)	1980-09-08
SE440778B (sv)	1985-08-19
DK151884C (da)	1988-06-13
IL59524A0 (en)	1980-06-30
IT1218420B (it)	1990-04-19
PL222470A1 (nl)	1980-12-01
ES496889A0 (es)	1982-08-01
AU5623180A (en)	1980-09-11
SU1277894A3 (ru)	1986-12-15
NZ193052A (en)	1984-07-06
NL182959C (nl)	1988-06-16
AT375366B (de)	1984-07-25
CS253702B2 (en)	1987-12-17
ES8205789A1 (es)	1982-08-01
AR227015A1 (es)	1982-09-15
JPS6141513B2 (nl)	1986-09-16

Publication	Publication Date	Title
ZA801328B (en)	1981-03-25	Therapeutic agents
GB2000136B (en)	1982-01-06	Therapeutic agents
GB2005248B (en)	1982-03-24	Therapeutic agents
ZA782816B (en)	1979-05-30	Therapeutic agents
ZA80298B (en)	1981-08-26	Therapeutic agents
GB2000138B (en)	1982-03-03	Therapeutic agents
ZA796708B (en)	1981-08-26	Therapeutic agents
GB2000131B (en)	1982-01-13	Therapeutic agents
EG16606A (en)	1989-01-30	Therapeutic agents
ZA792390B (en)	1980-07-30	Therapeutic agents
GB2013181B (en)	1982-06-03	Therapeutic agents
GB2004876B (en)	1982-03-10	Therapeutic agents
GB2007656B (en)	1982-05-19	Therapeutic agents
GB2019836B (en)	1982-06-03	Therapeutic agents
GB2053910B (en)	1983-04-20	Pyridylaminotriazole therapeutic agents
GB2047691B (en)	1983-07-20	Therapeutic agents
GB2000510B (en)	1982-01-27	Therapeutic agents
GB2011890B (en)	1982-05-26	Therapeutic agents
GB2010824B (en)	1982-06-16	Therapeutic agents
GB2013179B (en)	1982-06-03	Therapeutic agents
GB2011891B (en)	1982-05-26	Therapeutic agents
GB2007654B (en)	1982-06-16	Therapeutic agents
GB2008104B (en)	1982-03-10	Therapeutic agents
ZA803988B (en)	1982-02-24	Novel therapeutic combinations
GB2000441B (en)	1982-01-06	Therapeutic agents